Choosing the right inhaler for your asthma or COPD patient
OS Usmani - Therapeutics and clinical risk management, 2019 - Taylor & Francis
Appropriate selection and correct use of inhalation devices is an integral component in the
management of asthma and chronic obstructive pulmonary disease (COPD). It is well known …
management of asthma and chronic obstructive pulmonary disease (COPD). It is well known …
[HTML][HTML] Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
AJK Wilkinson, R Braggins, I Steinbach, J Smith - BMJ open, 2019 - bmjopen.bmj.com
Objectives Metered-dose inhalers (MDIs) contain propellants which are potent greenhouse
gases. Many agencies propose a switch to alternative, low global warming potential (GWP) …
gases. Many agencies propose a switch to alternative, low global warming potential (GWP) …
2023 Canadian Thoracic Society guideline on pharmacotherapy in patients with stable COPD
Chronic obstructive pulmonary disease patient care must include confirming a diagnosis
with postbronchodilator spirometry. Because of the clinical heterogeneity and the reality that …
with postbronchodilator spirometry. Because of the clinical heterogeneity and the reality that …
Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
Inhaled medications are the cornerstone of treatment and management of asthma and
COPD. However, inhaler device errors are common among patients and have been linked …
COPD. However, inhaler device errors are common among patients and have been linked …
COPD‐X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update
IA Yang, JL Brown, J George, S Jenkins… - Medical Journal of …, 2017 - Wiley Online Library
Introduction: Chronic obstructive pulmonary disease (COPD) is characterised by persistent
respiratory symptoms and chronic airflow limitation, and is associated with exacerbations …
respiratory symptoms and chronic airflow limitation, and is associated with exacerbations …
Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
M Bogart, RH Stanford, F Laliberté… - … journal of chronic …, 2019 - Taylor & Francis
Introduction This longitudinal, retrospective cohort study of patients with COPD describes
baseline characteristics, adherence, and persistence following initiation of inhaled …
baseline characteristics, adherence, and persistence following initiation of inhaled …
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape
Inhaled therapies are the cornerstone of treatment in asthma and chronic obstructive
pulmonary disease, and there are a multitude of devices available. There is, however, a …
pulmonary disease, and there are a multitude of devices available. There is, however, a …
Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: a randomized controlled study
Background COPD is characterised by a progressive airflow limitation in the lungs.
However, adherence to therapy improves management of symptoms and delays disease …
However, adherence to therapy improves management of symptoms and delays disease …
Factors associated with appropriate inhaler use in patients with COPD–lessons from the REAL survey
D Price, DL Keininger, B Viswanad… - … journal of chronic …, 2018 - Taylor & Francis
Background Nonadherence to medication and incorrect use of inhalers represent significant
barriers to optimal disease management of patients with chronic obstructive pulmonary …
barriers to optimal disease management of patients with chronic obstructive pulmonary …
COPD‐X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update
E Dabscheck, J George, K Hermann… - Medical Journal of …, 2022 - Wiley Online Library
Introduction Chronic obstructive pulmonary disease (COPD) is a treatable and preventable
disease characterised by persistent respiratory symptoms and chronic airflow limitation on …
disease characterised by persistent respiratory symptoms and chronic airflow limitation on …